Cause and duration of heart failure may impact on the response to sacubitril/valsartan in patients with heart failure and reduced ejection fraction

被引：0
|
作者：
Mandal, Amit K. J. [1 ]
Missouris, Constantinos G. [1 ,2 ]
机构：
[1] Frimley Hlth NHS Fdn Trust, Dept Cardiol, Wexham Pk Hosp, Slough, Berks, England
[2] Univ Cyprus, Dept Cardiol, Sch Med, Nicosia, Cyprus
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2021年 / 22卷 / 03期
关键词：
D O I：
10.2459/JCM.0000000000001111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [1] Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
    Mohebi, Reza
    Liu, Yuxi
    Felker, G. Michael
    Prescott, Margaret F.
    Ward, Jonathan H.
    Pina, Ileana L.
    Butler, Javed
    Solomon, Scott D.
    Januzzi, James L.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) : 1673 - 1682
  • [2] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [3] Change in QRS duration as a predictor for response to sacubitril valsartan in heart failure reduced ejection fraction
    Kim, B.
    Park, H. S.
    Im, S. I.
    Kim, H. S.
    Heo, J. H.
    Cha, T. J.
    Cho, K. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 91 - 91
  • [4] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [5] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Barman, Hasan Ali
    Tanyolac, Selim
    Dogan, Omer
    Bal, Erdem
    Atici, Adem
    Ozyildirim, Serhan
    Yigit, Zerrin
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 533 - 540
  • [6] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [7] Change in Qrs Duration Asa Predictor for Response to Sacubitril/valsartan in Heart Failure With Reduced Ejection Fraction
    Kim, Bong Joon
    Park, Han Su
    CIRCULATION, 2019, 140
  • [8] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [9] Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pere Pericas
    Caterina Mas-Lladó
    Maria Francisca Ramis-Barceló
    Isabel Valadrón
    Marta Noris Mora
    Lucía Pasamar Márquez
    Rosa González Colino
    José Francisco Forteza Albertí
    Vicente Peral Disdier
    Xavier Rossello
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 167 - 175
  • [10] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
12345